In focus · trending topic

AF

31 stories · following the connections

ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial

By Nasdaq OMXJan 8, 2018, 1:31 PM UTC

BioSig Technologies Appoints New Chief Financial Officer to Facilitate Growth Trajectory

By Nasdaq OMXJan 3, 2018, 1:02 PM UTC

BioSig Technologies to Present at Digital Medicine & Medtech Showcase at Biotech Showcase

By Nasdaq OMXDec 28, 2017, 1:00 PM UTC

BioSig Technologies Issues Shareholder Letter for 2017

By Nasdaq OMXDec 21, 2017, 1:00 PM UTC

BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission

By Nasdaq OMXNov 14, 2017, 1:00 PM UTC

BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization

By Nasdaq OMXOct 24, 2017, 12:00 PM UTC

BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022

By Nasdaq OMXOct 19, 2017, 12:00 PM UTC

BioSig Technologies to Present at the Dawson James Small Cap Growth Conference

By Nasdaq OMXOct 13, 2017, 12:00 PM UTC